Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Sensorion

< Previous 1 2 3 4 Next >
Sensorion Announces US FDA Grants Rare Pediatric Disease Designation to OTOF-GT for the Treatment of Otoferlin Gene-Mediated Hearing Loss
From Sensorion
Via Business Wire
Sensorion Announces Approval to Initiate amended Phase 2a Proof of Concept Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity in France
From Sensorion
Via Business Wire
Sensorion to Present at the European Society of Gene & Cell Therapy (ESGCT) and the Gene Therapy for Rare Disorders Europe conferences in October 2022
From Sensorion
Via Business Wire
Sensorion to Participate in Various Upcoming Investor Conferences
From Sensorion
Via Business Wire
Sensorion Reports 2022 First Half Results
From Sensorion
Via Business Wire
Sensorion Announces First Patient Enrolled in Proof-of-Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation
From Sensorion
Via Business Wire
Sensorion Receives Positive Opinion for Orphan Drug Designation for OTOF-GT for the Treatment of Otoferlin Gene-Mediated Hearing Loss From the European Medicine Agency
From Sensorion
Via Business Wire
Sensorion to participate in the Inner Ear Biology Workshop in September 2022
From Sensorion
Via Business Wire
Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium and Cell & Gene Therapy Summit Conferences in July 2022
From Sensorion
Via Business Wire
Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation
From Sensorion
Via Business Wire
Sensorion to Participate in the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 29, 2022
From Sensorion
Via Business Wire
Sensorion to Present at the Inner Ear Disorder Therapeutics Summit in June 2022
From Sensorion
Via Business Wire
Sensorion to Present at the Gene Therapy Development and Manufacturing Conference in June 2022
From Sensorion
Via Business Wire
Sensorion Announces Approval in France to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation
From Sensorion
Via Business Wire
Sensorion Publishes Results of Combined General Meeting Resolutions
From Sensorion
Via Business Wire
Sensorion to Attend the American Society of Gene & Cell Therapy (ASGCT) and Gene Therapy Analytical Development Conferences in May 2022
From Sensorion
Via Business Wire
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 31, 2022
From Sensorion
Via Business Wire
Sensorion Announces the Publication of Its 2021 Annual Financial Report
From Sensorion
Via Business Wire
Sensorion Full-Year 2021 Financial Results and Business Highlights
From Sensorion
Via Business Wire
Sensorion Will Participate in Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit Held Virtually on April 26, 2022
From Sensorion
Via Business Wire
Sensorion Publishes Results of Extraordinary General Meeting Resolutions
From Sensorion
Via Business Wire
Sensorion to Attend the Kempen Life Sciences, Cell & Gene Meeting on the Mediterranean Conferences in April 2022
From Sensorion
Via Business Wire
Sensorion Will Present at The H.C. Wainwright Gene Therapy and Gene Editing Virtual Conference on March 30th, 2022
From Sensorion
Via Business Wire
Sensorion Provides Preliminary Documents for the Extraordinary General Meeting of April 14th, 2022
From Sensorion
Via Business Wire
Sensorion Will Present at the Bioprocessing Summit Europe Conference on March 22, 2022 in Barcelona
From Sensorion
Via Business Wire
Sensorion Update on SENS-401
From Sensorion
Via Business Wire
Sensorion to Present Three Posters on SENS-401 in Cisplatin Ototoxicity Models at the Association for Research in Otolaryngology (ARO) 45th Annual MidWinter Meeting
From Sensorion
Via Business Wire
Sensorion to Present New Data on OTOF Gene Therapy at the Association for Research in Otolaryngology ARO 45th Annual MidWinter Meeting
From Sensorion
Via Business Wire
Sensorion Updates on SENS-401 Phase 2 trial in Sudden Sensorineural Hearing Loss
From Sensorion
Via Business Wire
Sensorion appoints Aniz Girach as Independent Board Member
From Sensorion
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback